Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
- 1 January 1990
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 14 (2) , 137-in2
- https://doi.org/10.1016/0278-5846(90)90097-z
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Fluoxetine subsensitizes a nicotinic mechanism involved in the regulation of core temperatureLife Sciences, 1987
- Cholinergic mechanisms in affective disordersActa Psychiatrica Scandinavica, 1986
- Co-Release of ACTH and β-Endorphin Immunoreactivity in Human Subjects in Response to Central Cholinergic StimulationScience, 1983
- Presynaptic ReceptorsAnnual Review of Pharmacology and Toxicology, 1981
- Cholinergic rebound in neuroleptic withdrawal syndromesPsychosomatics, 1981
- Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatmentNature, 1980
- In vitro Regulation of ACTH Release from Neurointermediate Lobe of Rat HypophysisNeuroendocrinology, 1979
- REM Sleep Induction by Physostigmine Infusion During SleepScience, 1976
- WITHDRAWAL SYMPTOMS IN NEONATES ASSOCIATED WITH MATERNAL ANTIDEPRESSANT THERAPYThe Lancet, 1973
- A cholinergic mechanism in the brainstem reticular formation: Induction of paradoxical sleepInternational Journal of Neuropharmacology, 1964